Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Juravinski Cancer Center
With
McMaster University
Mitacs
Northern Ontario School of Medicine
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
A confirmed diagnosis of prostate cancer.
Having undergone prior prostate surgery or radiotherapy or both.
You may not be if
Prior treatment with chemotherapy and/or abiraterone and/or enzalutamide and/or radium-223.
Receiving treatment with immunosuppressive medications.
Platelet count below 50,000/µl (50 x 109/l) or leukocyte count below 3,000/µl (3 x 109/l) or granulocyte count below 2,000/µl (2 x 109/l).
Other medical conditions or co-morbidities which, in the opinion of the Investigator, may interfere with the participant's ability to participate in the study.
Language difficulties which may hinder the patient's ability to complete the trial.
Inability of the potential participant to provide consent.
Lack of independence in daily living activities and any other conditions which, in the opinion of the Investigator, will hinder the participant's ability to participate and complete the study obligations.
Clareo Health | Low Dose Hemi-body Radiation For Recurrent Prostate Cancer
